Last Updated on October 2, 2024 by The Health Master
Cipla announced that its wholly-owned subsidiary, Cipla USA Inc, is voluntarily recalling six batches of Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation) manufactured in November 2021 to the consumer level.
Detail of batches:
| Sr. No | Product Name | Batch No | Expiry Date |
| 1 | Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 MI) | IB20045 | Nov.2023 |
| 2 | Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 MI) | IB20055 | Nov.2023 |
| 3 | Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 MI) | IB20056 | Nov.2023 |
| 4 | Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 MI) | IB20057 | Nov.2023 |
| 5 | Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 MI) | IB20059 | Nov.2023 |
| 6 | Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 MI) | IB20072 | Nov.2023 |
In a statement, the company said:
“There is a reasonable probability that failure to deliver the recommended dose to treat the respiratory symptoms of acute asthma exacerbations such as wheezing coughing, shortness of breath and bronchospasms, due to device defect, may be life-threatening.”
“There were no adverse events reported for Albuterol Sulfate Inhalation Aerosol 90 mcg related to this recall.”
“The company is initiating a recall in the US due to a market complaint for one single inhaler (Batch Number – IB20056), where leakage was observed through the inhaler valve.”
“Out of an abundance of precaution, of the above mentioned six batches manufactured using the same lot of valves are being recalled.”
The product is used for the treatment and prevention of bronchospasm with reversible obstructive airway disease and for the prevention of exercise induced bronchospasm.
The product is packaged in 17ml plain aluminium aerosol canister integrated with dose counter coupled with plastic actuator and dust cap, each pack claims 200 metered inhalations and associated codes NDC-69097-142- 60.
These six batches were distributed Nationwide to wholesalers and retailers.
Cipla is notifying its distributors and customers by letter and is arranging for return and replacement of all recalled products.
Consumers / distributors / retailers that have product from these six batches which are being recalled should stop using/return to place of purchase / discard.
This recall is being conducted with the knowledge of the US Food and Drug Administration (USFDA)
Understanding GMP, cGMP, and WHO-GMP
Drug recall: Typhoid vaccine recalled due to this reason
Drug recall: Pediatric Drops recalled due to this reason
Drug recall: 24,194 Prefilled Syringes of generic medication recalled due to this reason
Drug recall: Thyronorm tablets recalled due to this reason
Drug recall: Sun Pharma, Hetero recall these drugs
Drug recall: 50,000 contaminated eye drops recalled
DCOIWA: A grand success of 1st Annual Congress Cum Workshop held at Delhi
USFDA issues EIR to Zydus Lifesciences for Pharmez Facility
India passes amendment to remove animals from Drug Trials
CDSCO introduces new Transfer Policy for Officers up to Deputy Drugs Controller (India)
DCOIWA presents the 1st Annual Congress Cum Workshop at Delhi
Price cap on concentrators, 5 other Medical Devices extended
High Court refuses to stay ban on 14 FDCs: Gujarat
NSQ drug: FDA takes action against Pharma Company and Medical Store
High Court restrains Glenmark from selling this Asthma drug
Medical Store: Proposal to amend criteria for issuing Sale Licences
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
